ClinicalTrials.gov
public full text
Public Domain
A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults
The purpose of the study is to assess the effect of a therapeutic and supratherapeutic dose of zelicapavir on the corrected cardiac QT interval relative to a placebo and positive control in healthy participants.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine#875314
- A Through QT/QTc Study of KW-6356#1044761
- Sub-Q Versus IV Furosemide in Acute Heart Failure#1213215
- Use of Short Text Messages to Promote Medication Adherence in Hypertensive Patients#878418
- Effects on the Qt Interval of COVID-19 Coronavirus Infection#883382
Record · ID 1282291
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive